CureMatch
×
  • Physicians
  • Patients
  • Employers
  • About Us
  • News
    • CureMatch News
    • Validation and Research
    • Events & Conferences
  • Contact
  • Login
Steven Eisenberg, DO

Steven Eisenberg, DO

ONCOLOGIST & HEMATOLOGIST, CALIFORNIA CANCER ASSOCIATES FOR RESEARCH AND EXCELLENCE (cCARE)

Dr. Eisenberg received his Doctor of Osteopathic Medicine degree from the Philadelphia College of Osteopathic Medicine and his undergraduate degree from Pennsylvania State University. He completed an internship and residency in internal medicine at the Philadelphia College of Osteopathic Medicine Hospital Consortium where he served as chief intern. Dr. Eisenberg continued his postgraduate education by serving a fellowship in hematology/oncology at Georgetown University Hospital, Vincent T. Lombardi Comprehensive Cancer Center.

Dr. Eisenberg has co-authored several articles in scientific journals on topics related to colon cancer. A diplomate of the American Osteopathic Board of Internal Medicine, his professional activities include membership in the American Osteopathic Association and the American Society of Clinical Oncology. He has been recognized by the American Medical Association for his commitment to continuing medical education with the Physician’s Recognition Award. Dr. Eisenberg’s personal interests include music, tennis, skiing, martial arts, painting and photography.

logo

+1 (858) 284-0488

FAX: +1 (858) 430-5813

Quick Links

  • Physicians
  • About CureMatch
  • News and Latest Posts
    • CureMatch News
    • Validation and Case Studies
    • Events and Conferences
  • Contact Us
  • FAQ

Latest News and Results

  • Interview with Dr. Razelle Kurzrock of CureMatch: Why Patients Need Precision Cancer Medicine Apr 6

    In this dynamic interview, Chief Medical Advisor, Dr. Kurzrock, sits down with Michelle Morand, Co-Founder...

  • New Study Validates Payer/Physician Use of AI to Cut Wasteful Spending on High-Cost, Low-Value Cancer Drugs Mar 28

    The Research Consortium announced the release of a new study today that challenges common misconceptions...

  • CureMatch Names Life Sciences Executive David Szekeres as Board Director Feb 22

    CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine...

© 2021 CureMatch, Inc. CureMatch is a registered trademark.
Terms of Use | Privacy Policy | HIPAA Notice

We’d like to send you a CureMatch Sample Analysis

 

Sample Analysis Download Form

  • This field is for validation purposes and should be left unchanged.

 

We value and respect your privacy and will not publish, share, or sell your contact information.

View Privacy Policy

Some pages of this website are intended for healthcare professionals

This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.

Otherwise, you will be redirected to the institutional part of this website.

Thank you for your understanding.

I am a healthcare professionalI am not a healthcare professional

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data